A chemotherapy drug that is supposed to help save cancer patients' lives, instead resulted in life-threatening and sometimes fatal allergic reactions. A new study identified 287 hypersensitivity reactions and 109 deaths in patients who received Cremophor-based paclitaxel, a solvent-administered chemotherapy. Two patients who died from an allergic reaction had highly curable early-stage breast cancer. The allergic reactions are believed to be caused by the solvent, and the actual number of deaths is likely higher.
- Common chemotherapy drug triggers fatal allergic reactionsMon, 8 Jun 2009, 14:29:37 EDT
- Study shows that allergic reactions to Plavix can be treated with steroids and antihistaminesMon, 30 Mar 2009, 11:09:47 EDT
- Multi-tasking molecule holds key to allergic reactionsThu, 7 Aug 2008, 12:37:24 EDT
- Study identifies causes for high rates of allergic reactions in children with food allergiesMon, 25 Jun 2012, 15:04:26 EDT
- Promoting recovery from effects of severe allergic reactionMon, 19 Apr 2010, 18:48:23 EDT